Cargando…
Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions
Interleukin-4 (IL-4) is an immunomodulatory cytokine, which can inhibit the growth of tumour cells. Pancreatic cancer cells and tissues express high levels of IL-4 receptors. The aim of this study was to characterise the effects of IL-4 on the growth and signalling pathways of pancreatic cancer cell...
Autores principales: | Prokopchuk, O, Liu, Y, Henne-Bruns, D, Kornmann, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361902/ https://www.ncbi.nlm.nih.gov/pubmed/15714203 http://dx.doi.org/10.1038/sj.bjc.6602416 |
Ejemplares similares
-
Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression
por: Chen, G, et al.
Publicado: (2010) -
Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism
por: Théou-Anton, N, et al.
Publicado: (2006) -
Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells
por: Yamamoto, K, et al.
Publicado: (2012) -
Significance of nerve growth factor overexpression and its autocrine loop in oesophageal squamous cell carcinoma
por: Tsunoda, S, et al.
Publicado: (2006) -
Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)